Windlas Biotech Limited Stock

Equities

WINDLAS

INE0H5O01029

Pharmaceuticals

Market Closed - NSE India S.E. 07:40:49 2024-05-16 EDT 5-day change 1st Jan Change
544.2 INR +1.27% Intraday chart for Windlas Biotech Limited +3.35% +26.92%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 4.66B 55.83M 76.03M Sales 2023 5.13B 61.48M 83.72M Capitalization 4.71B 56.49M 76.94M
Net income 2022 381M 4.57M 6.22M Net income 2023 426M 5.1M 6.95M EV / Sales 2022 0.62 x
Net cash position 2022 1.69B 20.3M 27.64M Net cash position 2023 1.27B 15.21M 20.72M EV / Sales 2023 0.67 x
P/E ratio 2022
11.3 x
P/E ratio 2023
11.4 x
Employees 1,049
Yield 2022
1.67%
Yield 2023
1.78%
Free-Float 37.18%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.27%
1 week+3.35%
Current month-1.56%
1 month+2.97%
3 months+6.04%
6 months+30.40%
Current year+26.92%
More quotes
1 week
499.20
Extreme 499.2
551.25
1 month
495.65
Extreme 495.65
579.00
Current year
452.55
Extreme 452.55
590.85
1 year
260.10
Extreme 260.1
590.85
3 years
203.25
Extreme 203.25
590.85
5 years
203.25
Extreme 203.25
590.85
10 years
203.25
Extreme 203.25
590.85
More quotes
Managers TitleAgeSince
Chief Executive Officer - 15-10-15
Founder 73 00-12-31
Compliance Officer - 21-03-17
Members of the board TitleAgeSince
Chairman 57 21-05-05
Director/Board Member 47 21-05-03
Founder 73 00-12-31
More insiders
Date Price Change Volume
24-05-16 544.2 +1.27% 42,226
24-05-15 537.4 +0.26% 27,228
24-05-14 536 +4.31% 38,451
24-05-13 513.8 +1.83% 27,458
24-05-10 504.6 +0.07% 35,375

Delayed Quote NSE India S.E., May 16, 2024 at 07:40 am

More quotes
Windlas Biotech Limited is an India-based company that is primarily engaged in the manufacturing and trading of pharmaceutical products. The Company provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. It has capabilities for both solid and liquid pharmaceutical dosage forms. The Company markets its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. It also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. WINDLAS Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW